Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2025 Apr 7;19(4):e0012983. doi: 10.1371/journal.pntd.0012983

“Survey on the burden, epidemiological and clinical characteristics of snakebite envenoming in the Health Demographic Surveillance System (HDSS) of Taabo (Southern Côte d’Ivoire)”

Tanoh Amany Serge Raymond N’Krumah 1,2,*, Bognan Valentin Koné 2, Yao Didier Koffi 2,3, Dognimin Ismael Coulibaly 1,2, Abdoulaye Tall 2, Siaka Koné 2, Simone Toppino 4, Marija Stojkovic 4, Bassirou Bonfoh 2, Thomas Junghanss 4
Editor: Wuelton Monteiro5
PMCID: PMC12002634  PMID: 40193400

Abstract

Background

In Sub-Saharan Africa, reliable data on the burden, clinical epidemiology and management of snakebites remains scarce. Mostly, crude population and institution-based estimates have been reported. The aim of this study was to estimate the burden and describe the epidemiological and clinical characteristics of snakebite envenoming based on population- (HDSS) data.

Methods

A cross-sectional snakebite survey was conducted in all households in the Ahondo Health Area (AHA), a sub-population of the Taabo Health and Demographic Surveillance System (HDSS) between October 2 to December 22, 2023. All household members were interviewed, and a questionnaire was administered to snakebite cases. Epidemiological and clinical characteristics were described, and the annual snakebite incidence calculated.

Results

795 households were surveyed, representing 3,924 people in the AHA. The annual incidence of snakebites per 100,000 population was 280.3 (CI: 140.0 - 501.0), the case-fatality rate 2.0% (95%CI: 0.04 - 10.5) and the median age of snakebite victims 43 years. The annual incidence of snakebites was significantly higher in the seasonally used agricultural camps (3296.7 cases per 100,000 inhabitants) than in the villages (208.7 cases per 100,000 inhabitants). Snakebites most frequently occurred in the morning and at night. Patients employed dangerous “first aid” measures. Most snakebite victims were treated by traditional healers. None of the cases attending the health services received antivenoms.

Conclusion

Snakebite envenoming remains a threat for rural communities at an unacceptable high level unchanged since the second half of the last century. Reliable community-based data on the incidence, circumstances and management of snakebite envenoming is only the first step to mitigate the neglected health problem. Implementation of prevention measures, first aid and clinical management, including access to antivenoms, must immediately follow.

Author summary

Snakebite envenoming is an important health threat to rural communities in many parts of the world. In Sub-Saharan Africa reliable data on the burden, clinical epidemiology and management of snakebites remain scarce. In our wound management project “Prevent, identify & treat wounds early: An integrated sectoral community-based approach” we found a substantial proportion of wounds which were most probably caused by snakebites. They were neither linked to snakebite by patients nor diagnosed as snakebite wounds by health staff in patients presenting to the health services. This observation prompted us to add an in-depth snakebite study to our wound management project estimating the burden and describing the epidemiological and clinical characteristics of snakebites. The annual incidence of snakebites in our study area was 280 cases per 100,000 population unchanged since the 70ies of the last century. The death of a 13-year-old teenager bitten by a green mamba is a very sad avoidable death due to the lack of education in snakebite prevention and first aid at the community and training and resources including antivenom at the health services level.

Introduction

Snakebite envenoming listed as a Neglected Tropical Disease (NTD) in 2017 is a disease of the rural poor. Every year, it causes worldwide a substantial number of deaths and permanent disability in survivors, including restricted mobility, amputation, blindness, and psychological effects [16]. Snakebite and snakebite envenoming is reviewed by Gutiérrez et al [7], Warrell [8], and for Africa by Chippaux [9]. The WHO Snakebite information and data platform is a continuously updated resource [10].

In Sub-Saharan Africa, reliable data on the burden, prevention and management of snakebites remains scarce. Mostly, crude population and institution-based estimates have been reported [9,11,12]. The latter are biased since most patients do not reach health facilities and, additionally, are not systematically reported.

In Sub-Saharan Africa, the annual incidence estimates are 56 per 100,000 population (95% CI: 45–68/100 000) based on hospital data and 204 per 100,000 population (95% CI: 172–237/100 000) based on household surveys with a case fatality rate between 2.8% and 11.6% depending on whether antivenom was used. The incidence of sequelae may be in the range of 5% and amputations 3% [12].

Snake bite deaths are estimated at 20 000 – 32 000 people per year, most likely a cross underestimation [13].

High at-risk groups are rural agricultural workers, pastoralists, fishermen, hunters, children, people living in poorly constructed houses, and those with limited access to education and healthcare [9,14]. The shared environment of humans and venomous snakes and its implications has been described [9]; very detailed for the most important venomous snake in West Africa the saw scaled viper (Echis carinatus) [15].

The primary prevention measures, supportive and specific (antivenom) treatment are poorly developed across sub-Saharan Africa [9]. Guidelines for the prevention and management of snakebite envenoming have been published by WHO in 2010 [16].

In West Africa at least 3500–5350 deaths happen annually, equivalent to 1.2 deaths/100 000 population per annum (95% CI: 0.9–1.4/100 000) [17]. The underestimation of the snakebite burden in West Africa has been assessed by Habib et al [17].

In Côte d’Ivoire, a national household and health center-based epidemiological snakebite survey was carried out in 1979 and published in 2002, estimating the annual incidence of snakebites in rural areas at greater than 200 bites per 100,000 inhabitants, higher in forest areas (195 per 100,000 inhabitants) than in savannah areas (130 per 100,000 inhabitants).

The fatality rate was higher in savannahs (3.1%) than in forests (2.0%). More than half the bites occurred in men aged between 15 and 50, with a significantly higher risk among farmers [18]. Tiassalé health district, to which Taabo Health Demographic and Surveillance System (HDSS) belongs, was leading the snakebite case fatality rate (8.25%) in the national survey [18].

The Ahondo Health Area where our wound management project “Prevent, identify & treat wounds early: An integrated sectoral community-based approach” is carried out since 2019, is located in Taabo HDSS [19,20]. We found a substantial proportion of wounds which were most probably caused by snakebites. They were neither linked to snakebite by patients nor diagnosed as snakebite wounds by health staff in patients presenting to the health services. This observation prompted us to add an in-depth snakebite study to our wound management project.

The objective of the study was to estimate the annual snakebite incidence and to describe the epidemiological and clinical characteristics of snakebites in the HDSS setting of Ahondo Health Area (AHA).

Methods

Ethics statement

This study is part of the humanitarian and research project entitled “Prevent, identify & treat wounds early: An integrated sectoral community-based approach” carried out in the Taabo Health Demographic Surveillance System (HDSS). The study protocol was approved by the National Health and Life Sciences Ethics Committee (CNESVS) of Côte d’Ivoire (N/Ref: 025–22/MSHPCMU/CNESVS-km, dated March 03, 2022) and by the Ethical Review Board of the University Hospital of Heidelberg, Germany (N˚ 2021_EKHA.91, dated September 02, 2021). Written informed consent was obtained from all participants aged 18 years and older, or from parents, or legal representatives of persons younger than 18 years.

Study area

The study took place in the Ahondo Health Area (AHA) including Ahondo and Sahoua villages. AHA is part of the Taabo Health Demographic Surveillance System (HDSS) located in the Tiassalé health district (Fig 1).

Fig 1. Map of the Tiassalé Sanitary District in southern Côte d’Ivoire, including Taabo HDSS and Ahondo Health Area (Source: N’Krumah et al, [.

Fig 1

26], https://doi.org/10.1371/journal.pntd.0004327.g001).

The Taabo HDSS is a research station of the Centre Suisse de Recherche Scientifique en Côte d’Ivoire (CSRS) located in south-central Côte d’Ivoire, approximately 150 km northwest of Abidjan. Since its creation in 2009, research on integrated control of water-related diseases, such as schistosomiasis, malaria, and Buruli ulcer, etc., have been carried out. The Taabo HDSS covers an area of approximately 980 km2 located between latitudes 6°0’ and 6°20’ N and longitudes 4°55’ and 5°15’ W. The area is mainly rural and comprises 13 villages as well as an urban settlement (Taabo-Cité) [21].

The annual rainfall ranges between 600 and 2000 mm per year, with four distinct climatic seasons [22]. In Taabo, a hydroelectric dam of about 69 km2 was built on the Bandama River in the late 1970s. In 2019, AHA had a population of around 4,200 people representing 10% of the Taabo HDSS population. The livelihood mainly depends on agriculture. Ahondo Health Center (AHC) is the largest center in the health area and is located 15 km from the Taabo district hospital. Since December 2019, the Sahoua Health Center (SHC) has become active. The socio-sanitary situation of the Taabo HDSS in general and the AHA in particular is characterized by a high prevalence of wounds and Skin NTDs [19], communicable diseases such as malaria and schistosomiasis [23,24] and limited access to primary healthcare and safe drinking water [25]. In Ahondo, on the banks of the Bandama River, bananas are cultivated in plantations employing people of the villages. The banana plantation company is responsible for significant migrant worker movement in and out of AHA. The population of the AHA is diverse and representative of the Ivorian population composition.

Study design, definition of a “snakebite” case and rationale for the presented groups

We conducted a cross-sectional exhaustive survey based on the entire population of the Ahondo health area which is part of the Taabo HDSS. There were no exclusion criteria.

We capitalized on the HDSS infrastructure where demographic, health, socioeconomic, environmental, etc. data are routinely collected to analyze snakebite envenoming in its context.

Definition of a ‘snakebite’ case and rational for the presented groups

Definition of a ‘snakebite’ case:

  • A person reporting a snake/ the local name of the snake inflicting the bite.

  • signs & symptoms interpreted as being caused by a snakebite based on the features described in the syndromic approach to snakebite envenoming in Sub-Saharan Africa [27,28].

  • Formal identification of the offending snake by an expert familiar with the venomous snakes of the region.

Group 1: Persons in AHA reporting a snakebite as defined above between October 2, 2022 and October 2, 2023.

Assuming a low recall bias for snakebites (a dramatic event) within the previous 12 months, the annual snakebite incidence is calculated from Group 1 and the epidemiology and circumstances of the bites described.

Group 2: Persons in AHA reporting a snakebite as defined above before October 2, 2022.

The data of group 2 are used to get a broader insight into the regional snakebite problem accepting a higher recall bias compared to group 1.

Data collection

The household survey was carried out in AHA between October 2 and December 22, 2023, by a team consisting of two interviewers from the Taabo HDSS, trained in data collection using the Open Data Kit (ODK) software, a Community Health Worker (CHW), a physician, a sociologist, and an epidemiologist.

The snakebite survey is part of an ongoing project to assess the wound burden, and the impact of the community-based wound management model implemented in 2019. Since the project had just started replacing paper questionnaires/ CRFSs by ODK, the data was collected by two interviewers with an ODK tablet and a paper-based questionnaire to capture and correct data entry errors. To minimize absences from households, the survey was carried out in the evenings between 4 p.m. and 8 p.m., after household members had returned from their daily activities.

Once in the household, the interviewers explained the purpose of the survey to the head of the household and asked each household member if they had been a victim of snakebites at any time in their live with particular emphasis on snakebites they experienced in the past twelve months prior to the household survey. People temporarily absent from the household during the survey were systematically revisited the next day by the investigators. In households, in which a victim of snake bite was identified, a specific questionnaire was administered directly to the person of 10 years old or older and to the parents if the victim was less than 10 years old and after written informed consent of the victim had been obtained from adults (≥18 years old) or the parent/legal guardian if the victim was a minor (<18 years old). For the only fatal case, a teenager who died following a snakebite, the questionnaire was administered to his mother using the verbal autopsy method [29,30].

Data collected on snakebite victims included socio-demographic characteristics, environmental and social risk factors, and clinical characteristics (Table 1).

Table 1. Data collected from snakebite victims at the household survey in the Ahondo Health Area (AHA).

Socio-demographic and economic characteristics Environmental
characteristics
Snakebite
characteristics
Household HDSS ID Time of day of the bite Snakebite within the past 12 months
Individual HDSS ID Activity at the time of the bite Snakebite prior to the past 12 months
Household size Environment of the bite
Place of residence Snake observed at/ immediately after the bite (escaping snake)
Snake observed and “local name” reported
Snake species identified by an expert
Sex Signs & symptoms interpreted as being caused by a snakebite
Age A health professional diagnosing a snakebite
Nationality
Area of residence
School level Location of the bite
Marital status
Profession Swelling at the bite site
Swelling of the arm/leg or more extended
Housing type Inability to raise the head
Nature of the household wall Inability to lift the eyelids
Nature of household soil Inability to lift arms and/or legs
Location of household members’ defecation Bleeding from the bite site
Main water supply source Bleeding from the mouth
Main source of household lighting Red urine
Main household cooking method Loss of consciousness
Source of household income
Application of a black stone
Incision of the bite site
Application of a tourniquet

Self-medication

  • medical products

  • traditional products

Treatment

  • health services

  • traditional healer

Antivenom treatment at hospital
Victim living/ deceased

HDSS: Health demography surveillance system.

In addition, an interview was conducted with two nurses of AHA, a doctor of Taabo General Hospital and the manager of Taabo pharmacy. These interviews focused on

  • the medical treatment of snakebite;

  • the use of antivenom;

  • the availability of antivenom in Taabo pharmacy.

Data management and analysis

Data was entered and uploaded using Open Data Source (ODK central v2023) and exported to a Microsoft Excel CSV file. R software (version 4.3.1) was used for data analysis. The annual incidence of reported snakebites per 100,000 population for the AHA population was calculated from snakebites reported for the period October 2, 2022, to October 2, 2023, of Group 1. The proportions of sociodemographic, clinical and environmental variables were calculated for both groups. Results of group 1 and 2 are separately tabulated. The Fisher test statistics was used to compare the proportions of categorical variables at the 5% threshold. The interviews were analyzed to identify the main elements of interest of our study.

Results

Demographic and epidemiological data of the snakebite survey

During the survey, 795 households were enumerated, 4,474 people were counted, and 3,924 people surveyed. 519 people had out-migrated, and 31 people had died. A total of 11 snakebite cases were reported in the AHA population for the period October 2, 2022, to October 2, 2023 (Group 1), and 51 people currently living in the AHA suffered snakebites before October 2, 2022 (Group 2). The annual snakebite incidence per 100,000 population calculated from group 1 was 280.3 per 100,000 (CI: 140.0 - 501.0). The AHA snakebite case-fatality rate calculated from group 2 was 2.0% (95% CI: 0.05 - 10.5) (Table 2).

Table 2. Demographic and epidemiological data of snakebite victims of the household survey in the Ahondo Health Area (AHA).

Ahondo Health Area (AHA)
Demographic data
Number of households surveyed 795
Number of individuals surveyed in households 3924
Number of people out-migrated 519
Number of deceased individuals 31
Epidemiological data
Total cases 62
Group 1 (Victims of snakebite between October 2, 2022, and October 2, 2023)
Number of cases 11
Deaths attributed to snakebite 00
Annual incidence of snakebite per 100,000 population (95%CI) 280.3 (140.0 – 501.0)
Group 2 (Victims of snakebite before October 2, 2022)
Number of cases 51
Deaths attributed to snakebite 01
Case fatality rate as a percentage (95%CI) 2.0 (0.05 – 10.5)

CI: confidence interval.

Socio-demographic characteristics of snakebite victims

The demographic characteristics of snakebite victims in AHA Group 1 are summarized in Table 3.

Table 3. Demographic characteristics of group 1 snakebite victims of the household survey in the Ahondo Health Area (AHA).

Variables Group 1 (n = 11)
Number
(n)
Denominator (N) Annual incidence per 100,000 Confidence Interval (CI) p-value
Sex
Male 9 2022 445.1 (203.7 - 843.3) 0.067
Female 2 1902 105.2 (12.7 - 379.3)
Age in years: median (range) 43 (9-66)
< 15 1 1191 84.0 (2.1 - 466.9) 0.293
15 - 34 4 1212 330.0 (90.0 - 842.8)
35 - 54 5 989 505.6 (164.4 - 1175.8)
≥ 55 1 532 188.0 (4.8 - 1042.8)
Nationality
Côte d’Ivoire 6 2782 215.7 (79.2 - 468.8) 0.264
Burkina Faso 4 740 540.5 (147.5 - 1378.2)
Mali 1 297 336.7 (8.5 - 1861.6)
Area of residence
Village 8 3833 208.7 (90.1 - 410.8) 0.002*
Camps 3 91 3296.7 (685.1 - 9333.2)
School level
No school level 7 1873 373.7 (150.4 - 768.5) 0.058
Primary 3 1266 237.0 (48.9 - 690.9)
Secondary 1 785 127.4 (3.2 - 707.7)
Marital status
Single/Divorced/Widowed 5 1809 276.4 (89.8 - 643.8) 0.116
Married (traditional, civil) 5 924 541.1 (175.9 - 1258.3)
Not applicable 1 1191 84.0 (2.1 - 466.9)
Profession
Farmer 7 1735 403.5 (162.4 - 829.5) 0.072
Student 1 630 158.7 (4.0 - 881.2)
Housewife 2 104 1923.1 (233.7 - 6774.5)
Other professions 1 699 143.1 (3.6 - 794.5)

CI: confidence interval * Statistically significant.

In AHA, the annual incidence of snakebites was significantly higher in the camps (3296.7 cases per 100,000 inhabitants) than in the villages (208.7 cases per 100,000 inhabitants). The median age of snakebite victims was 43 years. For variables such as sex, age, nationality, profession, marital status and level of education of snakebite victims, there was no statistically significant difference between the different incidence classes at the 5% threshold.

The characteristics of the households of group 1 snakebite victims are presented in Table 4. Except for the “type of wall” variable in the households of group 1 snakebite victims, there was no statistically significant difference between the incidence categories of the other variables in the characteristics of the households of group 1 snakebite victims at the 5% threshold.

Table 4. Household characteristics of group 1 snakebite victims of the household survey in the Ahondo Health Area (AHA).

Variables Group 1 (n = 11)
Number
(n)
Denominator (N) Percentage (%) (95%CI) of Percentage p-value
Housing type
Traditional house 1 312 0.3 (0.01 - 1.8) 0.058
Traditional-modern house 10 483 2.1 (1.0 - 3.8)
Nature of the household wall
Cement brick wall 7 203 3.4 (1.4 - 7.0) 0.010*
Earth brick wall 4 592 0.7 (0.2 - 1.7)
Nature of household soil
Cemented 11 771 1.4 (0.8 - 2.5)
Uncemented 0 24 0
Location of household members’ defecation
Latrine 9 572 1.5 (0.7 - 3.0) 0.737
Bush 2 223 0.9 (0.1 - 3.2)
Main water supply source
Village pump 9 673 1.3 (0.6 - 2.5) 0.681
Rivers 2 122 1.6 (0.2 - 5.8)
Main source of household lighting
Electricity 10 693 1.4 (0.7 - 2.6) 0.999
Other light source 1 102 1 (0.02 - 5.3)
Main household cooking method
Firewood 8 541 1.5 (0.6 - 2.9) 0.999
Others (Gas, charcoal) 3 254 1.2 (0.2 - 3.4)
Source of household income
Agricultural activities 10 570 1.8 0.8 – 3.2 0.308
Other activities 1 225 0.4 0.01 2.5

CI: confidence interval * Statistically significant.

Reported clinical characteristics and socio-environmental risk factors

Clinical characteristics of snakebite victims.

The clinical characteristics of the snakebite victims are presented in Table 5.

Table 5. Characteristics of the snakebites reported by victims of the household survey in the Ahondo Health Area (AHA).
Variables Group 1 (n = 11) Group 2 (n = 51)
Number (n) Percentage (%) (95% CI) of percentage Number (n) Percentage (%) (95% CI) of percentage
Location of the bite
Head 0 0 (0 - 28.5) 1 2.0 (0.1 - 10.4)
Upper limbs 1 9.1 (0.2 - 41.3) 8 15.7 (7.0 - 28.6)
Lower limbs 10 90.9 (58.7 - 99.8) 42 82.3 (69.1 - 91.6)
Swelling at the bite site
Yes 8 72.7 (39.0 - 94.0) 37 72.5 (58.3 - 84.1)
No 3 27.3 (6.0 - 61.0) 14 27.5 (15.9 - 41.7)
Swelling of the arm/leg and more extended
Yes 4 36.4 (10.9 - 69.2) 15 29.4 (17.5 - 43.8)
No 7 63.6 (30.8 - 89.1) 36 70.6 (56.2 - 82.5)
Inability to raise the head
Yes 0 0 (0 - 28.5) 1 2 (0.1 - 10.4)
No 11 100 (71.5 - 100) 50 98 (89.6 - 99.9)
Inability to lift the eyelids
Yes 0 0 (0 - 28.5) 1 2 (0.1 - 10.4)
No 11 100 (71.5 - 100) 50 98 (89.6 - 99.9)
Inability to lift arms and/or legs
Yes 0 0 (0 - 28.5) 1 2 (0.1 - 10.4)
No 11 100 (71.5 - 100) 50 98 (89.6 - 99.9)
Bleeding from the bite site
Yes 8 72.7 (39.0 - 94.0) 43 84.3 (71.4 - 93.0)
No 3 27.3 (6.0 - 61.0) 8 15.7 (7.0 - 28.6)
Bleeding from the mouth
Yes 0 0 (0 - 28.5) 0 0 (0.0 - 7.0)
No 11 100 (71.5 - 100) 51 100 (0.93 - 100)
Red urine
Yes 0 0 (0 - 28.5) 0 0 (0.0 - 7.0)
No 11 100 (71.5 - 100) 51 100 (0.93 - 100)
Loss of consciousness
Yes 0 0 (0 - 28.5) 1 2 (0.1 - 10.4)
No 11 100 (71.5 - 100) 50 98 (89.6 - 99.9)
Application of a black stone
Yes 3 27.3 (6.0 - 61.0) 16 31.4 (19.1 - 45.9)
No 8 72.7 (39.0 - 94.0) 35 68.6 (54.1 - 80.9)
Incision of the bite site
Yes 9 81.8 (48.2 - 97.7) 43 84.3 (71.4 - 93.0)
No 2 18.2 (2.3 - 51.8) 8 15.7 (7.0 - 28.6)
Self-medication
Medical products 3 27.3 (6.0 - 61.0) 9 17.6 (8.4 - 30.9)
Traditional products 8 72.7 (39.0 - 94.0) 42 82.4 (69.1 - 91.6)
Treatment
Health services 4 36.4 (10.9 - 69.2) 16 31.4 (19.1 - 45.9)
Traditional healer 7 63.6 (30.8 - 89.1) 35 68.6 (54.1 - 80.9)
Antivenom treatment at hospital
Yes 0 0 (0.0 - 60.2) 0 0 (0.0 - 20.1)
No 4 100 (39.8 - 100) 16 100 (79.4 - 100)
Applying a tourniquet
Yes 7 63.6 (30.8 - 89.1) 27 52.9 (38.5 - 67.1)
No 4 36.4 (10.9 - 69.2) 24 47.1 (32.9 - 61.5)
Snake observed at/ after the bite
Yes 8 72.7 (39.0 – 94.0) 31 60.8 (46.1 – 74.2)
No 3 27.3 (6.0 – 61.0) 20 39.2 (25.8 – 53.9)
Snake observed and attributed a “local name”
Poponé (Vipera sp.) 3 37.5 (8.5 - 75.5) 8 25.8 (11.9 - 44.6)
Woblé (Naja sp.) 2 25.0 (31.9 - 65.1) 7 22.6 (9.6 - 41.1)
Mamba vert (Dendroaspis sp.) 2 25.0 (31.9 - 65.1) 12 38.7 (21.8 - 57.8)
No name reported 1 12.5 (0.3 - 52.7) 4 9.7 (2.0 - 25.7)

CI: confidence interval.

Most victims reported signs and symptoms of envenoming. The majority of cases the bite occurred at the lower limb.

Swelling and bleeding at the bite site were most commonly observed.

More than half the cases applied a tourniquet after the snakebite. Nearly a third of snakebite victims consulted a health center, while more than half of cases a traditional healer.

None of the patients received antivenom according to health staff: “No snakebite victims treated in rural health centers receive antivenom, because we don’t have any. Patients are treated with antibiotics and anti-inflammatories and given anti-tetanus serum”.

Victims attributing a local name to the snakebite experienced mentioned Poponé (Vipera sp.), Woblé (Naja sp.) and Mamba vert (Dendroaspis sp.) as culprits. None of the culprits have been formally identified by an expert.

Socio-environmental findings of snakebites and snakes involved.

Socio-environmental findings reported by snakebite victims are presented in Table 6. Snakebites occurred most often during the main activity periods of the day and at night, most frequently in the fields during farm work.

Table 6. Socio-environmental findings reported by snakebite victims of the household survey in the Ahondo Health Area (AHA).
Variables Group 1 (n = 11) Group 2 (n = 51)
Number (n) Percentage (%) (95% CI) of percentage Number (n) Percentage (%) (95% CI) of percentage
Time of day of the bite
Dawn of the day 0 0 (0.2 - 41.3) 2 3.9 (0.5 - 13.5)
Morning 4 36.4 (10.9 - 69.2) 21 41.2 (27.6 - 55.8)
Midday/Afternoon 4 36.4 (10.9 - 69.2) 4 7.8 (2.2 - 18.9)
Evening 0 0 (0.2 - 41.3) 9 17.6 (8.4 - 30.9)
Night 3 27.3 (6.0 - 61.0) 15 29.4 (17.5 - 43.8)
Activity at the time of the bite
Working in the farm 7 63.6 (30.8 - 89.1) 20 39.2 (25.8 - 53.9)
Walking/hiking 0 0 (0.2 - 41.3) 5 9.8 (3.2 - 21.4)
Household activities 4 36.4 (10.9 - 69.2) 18 35.3 (22.4 - 49.9)
Fishing activities 0 0 (0.2 - 41.3) 6 11.8 (4.4 - 23.9)
Leisure activities 0 0 (0.2 - 41.3) 2 3.9 (0.5 - 13.5)
Environment of the bite
At home 4 36.4 (10.9 - 69.2) 15 29.4 (17.5 - 43.8)
At the side of the road 0 0 (0.2 - 41.3) 4 7.8 (2.2 - 18.9)
In the field/in the forest 7 63.6 (30.8 - 89.1) 25 49 (34.8 - 63.4)
In the river 0 0 (0.2 - 41.3) 6 11.8 (4.4 - 23.9)
On a tree 0 0 (0.2 - 41.3) 1 2 (0.1 - 10.4)

CI: confidence interval.

Discussion

The snakebite study conducted in the general population of the Ahondo Health Area (AHA) provides, for the first time, population (HDSS) based epidemiological and clinical characteristics of snakebites in southern Côte d’Ivoire. The snakebite survey is part of a research project assessing the wound burden and clinical epidemiology and evaluating the impact of a community-based wound management model implemented in 2019 and monitored since then [19,20]. The repeated wound surveys cover the entire AHA population.

We divided the data collected into two groups. To minimize recall bias for the calculation of the annual snakebite incidence, we used the data of the last 12 months (October 2, 2022, and October 2, 2023) prior to the time when the survey was conducted (group 1). For all other variables we merged the two data sets. On comparison, group 1 and group 2 data were interestingly very consistent.

The annual incidence of snakebites in AHA calculated from the group 1 data was 280.3 (CI: 140.0 - 501.0) per 100,000 inhabitants, exceeding the estimate for rural Côte d’Ivoire based on data of the 1970ies with 200 bites per 100,000 inhabitants [18].

In the AHA, the incidence of snakebites was significantly higher in the “camps” - agricultural areas where people periodically live and do seasonal field work - than in and around villages.

80% of snakebite victims identified in the 12 months preceding the survey (group 1), were aged between 15 and 54, an age range which was also reported by others [18,31,32].

The low incidence of snakebite victims aged under 15 years could be explained by the fact that children in this age range are under the close care of adults or are attending school and are therefore not overly involved in the agricultural working activities that are the main cause of snakebites.

The snakebite fatality rate in AHA group 2 was 2.0%. The snakebite case fatality rate found in our study corresponds to previous estimates of 2% in the forest areas, where the Taabo HDSS is located, and 3% in the savannah zone [18].

The snakebite death recorded in our study concerns a 13-year-old boy of the village Ahondo, He had been bitten several times on the head by a snake after climbing a coconut tree. “Coming down from the coconut tree and shouting that he had been bitten by a green snake, this child died after a few hours at the village health center”, according to the parents of the deceased. The teenager’s death can be attributed to a green mamba (Dendroaspis sp.), an elapid that has well adapted to humanized environments [33]. The very fast snake, with its powerful neurotoxic venom, is a major cause of fatal envenoming in Sub-Saharan Africa. The death of this teenager demonstrates two problems at the health services level: (i) the lack of knowledge on immediate supportive treatment such as ventilation of the patient and, (ii) the lack of access to antivenom.

Incidence figures, the affected population and the physical environment where snakebites were reported confirmed that envenoming is clustered in rural hotspots and in specific segments of the population [34].

Snakes are mostly not or only vaguely seen when the bite occurs. Surprisingly, between 60 and 70% of the snakebite victims of our study claimed that they had observed the snake. Consistent between group 1 and 2, the proportion of the offending snakes (local names) were attributed in similar proportions to “Poponé” (Vipera sp.), “Woblé” (Naja sp.) and “Mamba vert”, (Dendroaspis sp.) as the main culprits [35]. Snakebites occurred mainly during working hours (70%) and at night (27%), in farms and at home. The high proportion of snakebites among housewives (39%) could be explained by the fact that they are the first to get up in the morning for daily household activities, work in the gardens and in the fields. The risk of snakebites in and around the house at night, when snakes are most active, is high due to lack of lighting.

Bites occurred mainly at the lower extremities (90%) which is expected.

The clinical signs reported by most snakebite victims were swelling at the bite site (70%) and bleeding from the bite site (around 75%). In most cases reported clinical signs resolved without specific treatment leading to the wrong conclusion that the measures applied suffice in envenomed patients. The resolution indicates, instead, that only a small quantity of venom was injected if it was a venomous snake or the clinical signs observed were wrongly attributed to a venomous snake. The latter is a well-known reporting bias in incidents where a snake has not been unequivocally observed. This is especially a problem at night or in thick undergrowth away from footpaths. Dry bites which are in the range of 50% of venomous snake bites are additionally contributing to misinterpreting the danger on venomous snakes.

The fact that signs and symptoms of envenoming are often neither attributed to a snakebite by the victim nor, initially, by health staff has been confirmed in our wound management study.

Between May 2019 and July 2024, the wounds of thirteen out of more than three hundred patients with complicated or severe wounds treated at Taabo District Hospital were attributed to snakebite envenoming by the medical team of our wound management project (see Fig 2).

Fig 2. 65-year-old man with a severe chronic wound on the forefoot and lower left leg presenting to the wound management unit of our project after 3 months of traditional treatment.

Fig 2

(A). The patient was not aware of the snakebite and the health services he had attended did not suspect a snakebite as the cause. The course of events the patient reported was highly suggestive of a snakebite, most likely a spitting cobra (Naja sp.). Within 2 months of wound care healthy granulation tissue had developed (B). Final result after skin grafting (C).

The evolution and the time course of large soft tissue necrosis around cytotoxic snakebites distinguishes them clearly from other causes. One of the snakes responsible for predominately local tissue damage in the study area are spitting cobras (Naja sp.) [3638]

In a case series from Nigeria all 14 patients bitten by the spitting cobra Naja nigricolis reported developed swelling at the bite noticed after an interval of between three minutes and three hours. In most patients, the swelling was extended reaching its maximum within 36 hours of the bite. Transient local bleeding from the bite was noticed in five patients. Local tissue necrosis was detected in 10 patients within 5 days after the bite and complete breakdown followed quickly [36].

First aid is poorly established in Cote d’Ivoire. Black stones were used in 31% of snakebite victims in our study. Black stones are ineffective and there is very strong advice against their use [27]. Alarmingly 82% of the snakebite victims incised the skin at the bite side. Also, dangerous – particularly in regions with venomous snakes causing clotting disturbances - and, entirely ineffective. Between 50 and 60% applied tourniquets. Again here, a problem with first aid measures. If applied too tightly they cause significant local damage, if applied only loosely, they are useless.

In our study more than 60% of snakebite victims primarily consulted traditional healers. The high involvement of traditional healers in snakebite patients is one of the reasons why snakebite victims present late to the health services or not at all. At the same time, it is an opportunity if traditional healers could be convinced to cooperate and to be trained in snakebite prevention and professional referral to Health Centers and hospitals [3941].

A snakebite management plan, equipment and materials, including very importantly antivenoms, are, however, preconditions for the cooperation and the development of trust in the health services. In our study none of the snakebite victims treated at Ahondo Health Center and Taabo District Hospital received antivenom. Most snakebite victims attending Ahondo Health Center and Taabo District Hospital were treated with antibiotics, anti-inflammatory drugs, and received tetanus prophylaxis. Interviewed health staff commented: “This protocol for treating snakebite victims was put in place due to the lack of antivenom”. “High cost, low demand, the expiry date of antivenom and power cuts in Taabo are the main reasons for not ordering antivenom”.

Study limitations

The main limitation of the first snakebite study within the framework of our longitudinal population (HDSS) based wound management project is the size of the study population of around 4,000 inhabitants surveyed. Considering the size of the population it is remarkable that the main features of snakebite envenoming (clinical, environmental and persisting managerial deficits) of the region are captured, and the annual incidence found is within the range of previous estimates. Despite the small population we survey, we could clearly demonstrate in this first snakebite study in Taabo HDSS that snakebite is a problem in the Taabo HDSS area and that it is unattended. The wound management project is close to rollout in a larger population the entire Taabo HDSS with 78.000 inhabitants which will present an opportunity for a more representative population sample with the methodology well established in the present study.

Estimating the incidence of snakebites and capturing the data on the circumstances of the bite, the culprit, the clinical presentation and course of events including first aid and treatment are hampered by a range of problems:

(a) snakebite vs snakebite envenoming: Counting snakebites is illusive; most snakebites go unnoticed. Studies on snakebites mainly capture snakebite envenoming. Patterns of signs and symptoms depending on the venom composition of the offending snake help to diagnose patients who experienced clinically relevant venom injections. Regionally, the envenoming pattern can be fairly reliably attributed to snake genus [27,42]. (b) recall bias: We minimized the recall bias, in particular to not underestimate snakebite (snakebite envenoming) incidence, by only using data of the past 12 months prior to the survey. Snakebite envenoming if substantial is traumatic and remembered even for longer periods of time. (c) observation bias: We cannot rely on patients attributing the right cause to the accident they experienced. This happens in both directions. Fast developing necrotic wounds as described above is an example of not attributing a snakebite to the clinical findings. To the contrary, snakebites are regularly blamed for a wound which in fact had been caused by a thorn etc. the patient stepped in. In our study also staff of health services did not attribute snakebites to wounds which most likely had been caused by envenoming.

In summary, the study results reveal information and figures on snakebite envenoming and not snakebites in general. Inquiring a short period of time (12 months) in an HDSS setting as in our study is as close as possible to robust estimates of snakebite envenoming incidence and outcomes. An underestimation is likely due to a bias towards more severe envenoming and due to an observation bias attributing the clinical finding to other causes. This may be partly balanced by an overestimation due to an observation bias attributing other causes of the clinical findings to a snakebite.

Despite limitations, the results of this first study of snakebites in the Taabo HDSS are valuable to guide prevention, first aid and clinical management strategies and informing future research, as widely recommended [3,9,45].

In conclusion, the results of our study show that the snakebite burden in rural Southern Côte d’Ivoire remains in the range of what had been recorded in the second half of the last century and continues to be a significant health threat to the rural population at work and at home. First aid measures and clinical diagnosis and management including antivenom availability in the health services are entirely inappropriate. The dominant role of traditional healers cannot be converted into cooperation under these circumstances. A countrywide effort is urgently required to mitigate the threat of snakebite envenoming. The main points are (a) creating awareness and educating communities in snakebite prevention, first aid and recognition as an emergency requiring immediate referral to the health services, (b) training staff of health services in diagnosing and managing snakebite envenoming, (c) providing life-saving equipment (e.g., to manage respiratory failure), (d) stocking antivenoms and instruct its application (d) securing follow-up and rehabilitation including mental problems.

Supporting information

S1 Checklist. STROBE Checklist.

Statement—checklist of items that should be included in reports of observational studies.

(PDF)

pntd.0012983.s001.pdf (19.4KB, pdf)
S1 File. Survey form on snakebite envenoming in the Ahondo health area (Taabo HDSS - Côte d’Ivoire).

(PDF)

pntd.0012983.s002.pdf (220.1KB, pdf)

Acknowledgments

We would like to thank the investigators of the Health and Demographic Surveillance System (HDSS) of Taabo and the community health workers for their active involvement during the data collection in the Ahondo Health Area, the community members, the staff of the Ahondo and Sahoua health centers and the Taabo district hospital, as well as the manager of the Taabo pharmacy. Thanks to technical and administrative staff of Centre Suisse de Recherches Scientifique en Côte d’Ivoire, the Swiss Tropical and Public Health Institute (Swiss TPH) and the University Hospital of Heidelberg (Germany).

Data Availability

All relevant data are included in the manuscript and its supporting information files.

Funding Statement

This work was supported by the Else Kröner-Fresenius-Stiftung and Swiss Tropical and Public Health Institute (SwissTPH) under Proj. No/Partner: 2021_EKHA.091 / Uni Heidelberg / Swiss TPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Ahmed S, Koudou GB, Bagot M, Drabo F, Bougma WR, Pulford C, et al. Health and economic burden estimates of snakebite management upon health facilities in three regions of southern Burkina Faso. PLoS Negl Trop Dis. 2021;15(6):e0009464. doi: 10.1371/journal.pntd.0009464 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis. 2009;3(12):e569. doi: 10.1371/journal.pntd.0000569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases. Geneva: World Health Organization. 2023; Licence: CC BY-NC-SA 3.0 IGO. https://www.who.int/publications/i/item/9789240051423 [DOI] [PubMed] [Google Scholar]
  • 4.World Health Organization. Snakebite envenoming: A strategy for prevention and control. Geneva: World Health Organization; 2019a. https://www.who.int/publications/i/item/9789241515641 [Google Scholar]
  • 5.Williams SS, Wijesinghe CA, Jayamanne SF, Buckley NA, Dawson AH, Lalloo DG, et al. Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl Trop Dis. 2011;5(8):e1255. doi: 10.1371/journal.pntd.0001255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Afroz A, Siddiquea BN, Chowdhury HA, Jackson TN, Watt AD. Snakebite envenoming: A systematic review and meta-analysis of global morbidity and mortality. PLoS Negl Trop Dis. 2024;18(4):e0012080. doi: 10.1371/journal.pntd.0012080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17079. doi: 10.1038/nrdp.2017.79 [DOI] [PubMed] [Google Scholar]
  • 8.Warrell DA. Venomous and poisonous animals. In: Farrar J, Garcia PJ, Hotez T, Junghanss T, Kang G, Laloo D (eds.). Manson’s tropical diseases. 24th ed. Elsevier; 2023. [Google Scholar]
  • 9.Chippaux JP. Snakebite in Africa: current situation and urgent needs. Chapter 39. In: Mackessy SP. (Ed.). Handbook of venoms and toxins of reptiles (2nd ed.). CRC Press; 2021. doi: 10.1201/9780429054204 [DOI] [Google Scholar]
  • 10.World Health Organization. Snakebite information and data platform. Geneva: WHO Department of Control of Neglected Tropical Diseases; 2022. https://www.who.int/teams/control-of-neglected-tropical-diseases/snakebite-envenoming/snakebite-information-and-data-platform/ [Google Scholar]
  • 11.Halilu S, Iliyasu G, Hamza M, Chippaux J-P, Kuznik A, Habib AG. Snakebite burden in Sub-Saharan Africa: estimates from 41 countries. Toxicon. 2019;159:1–4. doi: 10.1016/j.toxicon.2018.12.002 [DOI] [PubMed] [Google Scholar]
  • 12.Chippaux J-P. Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach. Toxicon. 2011;57(4):586–99. doi: 10.1016/j.toxicon.2010.12.022 [DOI] [PubMed] [Google Scholar]
  • 13.Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218. doi: 10.1371/journal.pmed.0050218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Musah Y, Ameade EPK, Attuquayefio DK, Holbech LH. Epidemiology, ecology and human perceptions of snakebites in a savanna community of northern Ghana. PLoS Negl Trop Dis. 2019;13(8):e0007221. doi: 10.1371/journal.pntd.0007221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Warrell DA, Arnett C. The importance of bites by the saw-scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Trop. 1976;33(4):307–41. [PubMed] [Google Scholar]
  • 16.World Health Organization. Guidelines for the prevention and clinical management of snakebite in Africa. Brazzaville: World Health Organization Regional Office for Africa; 2010. (https://apps.who.int/iris/handle/10665/204458; WHO 2023 Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. https://iris.who.int/bitstream/handle/10665/369786/9789240074569-eng.pdf?sequence=1]. [Google Scholar]
  • 17.Habib AG, Kuznik A, Hamza M, Abdullahi MI, Chedi BA, Chippaux JP, et al. Snakebite is under appreciated: appraisal of burden from West Africa. PLoS Negl Trop Dis. 2015;9(9):e0004088. doi: 10.1371/journal.pntd.0004088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chippaux J. Epidémiologie des morsures de serpent en République de Côte d’Ivoire. Bull Soc Pathol Exot. 2002;95(3):167–71. [PubMed] [Google Scholar]
  • 19.Toppino S, N’Krumah RTAS, Kone BV, Koffi DY, Coulibaly ID, Tobian F, et al. Skin wounds in a rural setting of Côte d’Ivoire: Population-based assessment of the burden and clinical epidemiology. PLoS Negl Trop Dis. 2022;16(10):e0010608. doi: 10.1371/journal.pntd.0010608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Toppino S, Koffi DY, Kone BV, N’Krumah RTAS, Coulibaly ID, Tobian F, et al. Community-based wound management in a rural setting of Côte d’Ivoire. PLoS Negl Trop Dis. 2022;16(10):e0010730. doi: 10.1371/journal.pntd.0010730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Koné S, Bonfoh B, Probst-Hensch N, Utzinger J, N’Goran EK, Fink G. Impact of newly constructed primary healthcare centres on antenatal care attendance, facility delivery and all-cause mortality: quasi-experimental evidence from Taabo health and demographic surveillance system, Côte d’Ivoire. BMJ Open. 2022;12(1):e054355. doi: 10.1136/bmjopen-2021-054355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Doumbia M, Coulibaly JT, Silué DK, Cissé G, N’Dione J-A, Koné B. Effects of Climate Variability on Malaria Transmission in Southern Côte d’Ivoire, West Africa. Int J Environ Res Public Health. 2023;20(23):7102. doi: 10.3390/ijerph20237102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Bassa FK, Eze IC, Assaré RK, Essé C, Koné S, Acka F, et al. Prevalence of Schistosoma mono- and co-infections with multiple common parasites and associated risk factors and morbidity profile among adults in the Taabo health and demographic surveillance system, South-Central Côte d’Ivoire. Infect Dis Poverty. 2022;11(1):3. doi: 10.1186/s40249-021-00925-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Coulibaly G, Ouattara M, Dongo K, Hürlimann E, Bassa FK, Koné N, et al. Epidemiology of intestinal parasite infections in three departments of south-central Côte d’Ivoire before the implementation of a cluster-randomised trial. Parasite Epidemiol Control. 2018;3(2):63–76. doi: 10.1016/j.parepi.2018.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Koné S, Fürst T, Jaeger N, Esso L, Baïkoro N, Kouadio K, et al. Causes of death in the Taabo health and demographic surveillance system, Côte d’Ivoire, from 2009 to 2011. Global Health Action. 2015;8(1):27271. doi: 10.3402/gha.v8.27271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.N’krumah RTAS, Koné B, Tiembre I, Cissé G, Pluschke G, Tanner M, et al. Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d’Ivoire: A Case-Control Study. PLoS Negl Trop Dis. 2016;10(1):e0004327. doi: 10.1371/journal.pntd.0004327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.World Health Organization. Guidelines for the prevention and clinical management of snakebite in Africa. Geneva: World Health Organization; 2010. http://www.afro.Who.int/fr/groupes-organiques-et-programmes/dsd/medicaments-essentiels/edm-publications/2731-.html [Google Scholar]
  • 28.World Health Organization. Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO [Google Scholar]
  • 29.World Health Organization. Verbal autopsy standards: the 2012 WHO verbal autopsy instrument. World Health Organization. 2012. Available from: http://www.who.int/healthinfo/statistics/WHO_VA_2012_RC1_Instrument.pdf [Google Scholar]
  • 30.World Health Organization. Normes d’autopsie verbale: établissement et attribution de la cause de décès. Genève: World Health Organization; 2009. https://iris.who.int/bitstream/handle/10665/44056/9789442547214_fre.pdf?sequence=1 [Google Scholar]
  • 31.Larson PS, Ndemwa M, Thomas AF, Tamari N, Diela P, Changoma M, et al. Snakebite victim profiles and treatment-seeking behaviors in two regions of Kenya: results from a health demographic surveillance system. Trop Med Health. 2022;50(1):31. doi: 10.1186/s41182-022-00421-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Dossou AJ, Fandohan AB, Omara T, Chippaux J-P. Comprehensive Review of Epidemiology and Treatment of Snakebite Envenomation in West Africa: Case of Benin. J Trop Med. 2024;2024:8357312. doi: 10.1155/2024/8357312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Akaffou M, Koué-Bi T, Beïbro-Yaokokoré K. Etude de quelques paramètres écologiques des Elapidae de six villes de Côte d’Ivoire. Int J Biol Chem Sci. 2019;13(1):237–50. [Google Scholar]
  • 34.Gutiérrez JM. Snakebite envenoming from an Ecohealth perspective. Toxicon X. 2020;7:100043. doi: 10.1016/j.toxcx.2020.100043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Doucet J. Office de la Recherche Scientifique et Technique Outre-Mer (ORSTOM). Les serpents de la République de Côte d’Ivoire. Acta Tropica. 1963; N°3 et 4.
  • 36.Warrell DA, Greenwood BM, Davidson NM, Ormerod LD, Prentice CR. Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis). Q J Med. 1976;45(177):1–22. [PubMed] [Google Scholar]
  • 37.Chippaux JP, , Parie FX, Roland G, Keba M. Spitting cobra (Naja nigricollis) bite. Trans R Soc Trop Med Hyg. 1978;72(1):106. doi: 10.1016/0035-9203(78)90313-9 [DOI] [PubMed] [Google Scholar]
  • 38.Chippaux J-P, Madec Y, Amta P, Ntone R, Noël G, Clauteaux P, et al. Snakebites in Cameroon by Species Whose Effects Are Poorly Described. Trop Med Infect Dis. 2024;9(12):300. doi: 10.3390/tropicalmed9120300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Steinhorst J, Aglanu LM, Ravensbergen SJ, Dari CD, Abass KM, Mireku SO, et al. “The medicine is not for sale”: Practices of traditional healers in snakebite envenoming in Ghana. PLoS Negl Trop Dis. 2021;15(4):e0009298. doi: 10.1371/journal.pntd.0009298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Duda R, Monteiro WM, Giles-Vernick T. Integrating lay knowledge and practice into snakebite prevention and care in central Africa, a hotspot for envenomation. Toxicon X. 2021;11:100077. doi: 10.1016/j.toxcx.2021.100077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Chuat M, Alcoba G, Eyong J, Wanda F, Comte E, Nkwescheu A, et al. Dealing with snakebite in rural Cameroon: A qualitative investigation among victims and traditional healers. Toxicon X. 2021;9–10:100072. doi: 10.1016/j.toxcx.2021.100072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Williams DJ, Faiz MA, Abela-Ridder B, Ainsworth S, Bulfone TC, Nickerson AD, et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl Trop Dis. 2019;13(2):e0007059. doi: 10.1371/journal.pntd.0007059 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012983.r002

Decision Letter 0

Wuelton Monteiro

31 Jan 2025

PNTD-D-25-00039

Health and Demographic Surveillance System (HDSS) based survey on burden, epidemiological and clinical characteristics of snakebite envenoming in Southern Côte d'Ivoire

PLOS Neglected Tropical Diseases

Dear Dr. N'KRUMAH,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Apr 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Wuelton Monteiro, Ph.D.

Section Editor

PLOS Neglected Tropical Diseases

Wuelton Monteiro

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Journal Requirements:

1) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019.

2) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines:

https://journals.plos.org/plosntds/s/figures

3) Some material included in your submission may be copyrighted. According to PLOSu2019s copyright policy, authors who use figures or other material (e.g., graphics, clipart, maps) from another author or copyright holder must demonstrate or obtain permission to publish this material under the Creative Commons Attribution 4.0 International (CC BY 4.0) License used by PLOS journals. Please closely review the details of PLOSu2019s copyright requirements here: PLOS Licenses and Copyright. If you need to request permissions from a copyright holder, you may use PLOS's Copyright Content Permission form.

Please respond directly to this email and provide any known details concerning your material's license terms and permissions required for reuse, even if you have not yet obtained copyright permissions or are unsure of your material's copyright compatibility. Once you have responded and addressed all other outstanding technical requirements, you may resubmit your manuscript within Editorial Manager.

Potential Copyright Issues:

- Please confirm that you are the photographer of Figure 2, or provide written permission from the photographer to publish the photo(s) under our CC BY 4.0 license.

- Figure 1, Please provide a direct link to the base layer of the map (i.e., the country or region border shape) and ensure this is also included in the figure legend; and provide a link to the terms of use / license information for the base layer image or shapefile. We cannot publish proprietary or copyrighted maps (e.g. Google Maps, Mapquest) and the terms of use for your map base layer must be compatible with our CC BY 4.0 license.

Note: if you created the map in a software program like R or ArcGIS, please locate and indicate the source of the basemap shapefile onto which data has been plotted.

If your map was obtained from a copyrighted source please amend the figure so that the base map used is from an openly available source. Alternatively, please provide explicit written permission from the copyright holder granting you the right to publish the material under our CC BY 4.0 license.

If you are unsure whether you can use a map or not, please do reach out and we will be able to help you. The following websites are good examples of where you can source open access or public domain maps:

* U.S. Geological Survey (USGS) - All maps are in the public domain. (http://www.usgs.gov)

* PlaniGlobe - All maps are published under a Creative Commons license so please cite u201cPlaniGlobe, http://www.planiglobe.com, CC BY 2.0u201d in the image credit after the caption. (http://www.planiglobe.com/?lang=enl)

* Natural Earth - All maps are public domain. (http://www.naturalearthdata.com/about/terms-of-use/).

4) Please ensure that the funders and grant numbers match between the Financial Disclosure field and the Funding Information tab in your submission form. Note that the funders must be provided in the same order in both places as well.

- State the initials, alongside each funding source, of each author to receive each grant. For example: "This work was supported by the National Institutes of Health (####### to AM; ###### to CJ) and the National Science Foundation (###### to AM)."

- State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.".

If you did not receive any funding for this study, please simply state: u201cThe authors received no specific funding for this work.u201d

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The study clearly stated its objectives to estimate the burden and describe the epidemiological and clinical characteristics of snakebite envenoming based on population data. The study design appropriately addresses the study's goals, with the population clearly stated. The sample size power is sufficient, as 3,924 people were involved in the study, and the statistical analysis supports its conclusions. The study sought approval from the National Health and Life Sciences Ethics Committee.

Reviewer #2: The sampling technique does not seem at all clear or detailed.

I didn't see the sample size calculation anywhere. This has negative repercussions, as the small number of people who have experienced snakebite and venom does not provide adequate power to generalise the results.

In view of the small number of 11 people bitten by the snake over the study period, non-parametric statistics were indicated, but this is not the case for what the authors were able to do.

Can you justify the choice of design for this study ????

The article says nothing about how the sample size was calculated and nothing about the sampling technique used to select the household.

Reviewer #3: Small sample size but the study is well-designed and methodology explained very well.

Reviewer #4: - The study objectives are clearly presented.

- The population is clearly described and appropriate.

- The sample size is more than sufficient to ensure adequate power of the statistics generated.

- Correct statistical analysis has been used to support the conclusions.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The results are presented well and clearly articulated.

Reviewer #2: The annual snakebite incidence per 100,000 population calculated from group

264 1 was 280.3 per 100,000 (CI: 140.0 - 501.0). The AHA snakebite case-fatality rate calculated

265 from group 2 was 2.0% (95% CI : 0.05 - 10.5) (Table 2). Can you explain these very wide confidence intervals?

What is the relevance of the choice of these two comparison groups?

The annual incidence

43 of snakebites was significantly higher in seasonal agricultural camps

44 (3296.7 cases per 100,000 inhabitants) than in villages (208.7 cases per 100,000 inhabitants).

45 inhabitants). Wouldn't this result be different if the size were larger?

Have you tried a non-parametric multivariate model with incidence as the dependent variable, given that univariate analyses are not reassuring?

45 inhabitants). Snakebites occur most often in the morning and at night. Have you used a statistical test?

Reviewer #3: Can't really assess if the analysis matches the analysis plan. The results are logically presented. The sample size justification is missing.

Reviewer #4: - Analysis corresponds to the analysis plan

- Results are presented clearly and completely

- Figures (tables, images) are of sufficient quality to ensure clarity

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: The conclusion supports the data presented, outlines the limitations, and provides four recommendations that address public health relevance.

Reviewer #2: The authors do not explain how this data, which lacks power, can be used and generalised to advance knowledge.

Reviewer #3: The study effectively communicates its results making it easy for the reader to understand the burden of snakebites in the area. The authors have acknowledged the limitations.

Reviewer #4: - Conclusions are supported by the data presented

- The limitations of the analysis are clearly described

- The authors have clearly explained how the data can be useful in advancing overall understanding of the subject studied

- The subject poses a real public health problem

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: None

Reviewer #2: (No Response)

Reviewer #3: Some minor revisions could be using consistent terminology for envenoming. There is some interchanging of envenomation and envenoming. Stick to one term. Also the discussion section needs a bit of reordering because it seems to jump about. Consider reordering for smoother flow.

Reviewer #4: Minor Revision

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The study is a valuable addition to the knowledge on snakebite research, an area that is silently affecting many rural individuals. Therefore, it is essential to determine its impact on our communities to mitigate it. The study highlights certain significant findings, such as the fact that most snakebite victims average 43 years of age, and first aid measures are often inadequately applied. These issues deserve attention, and I commend the authors for their contributions to this field of knowledge.

Reviewer #2: The authors need to improve the writing on the sampling technique and improve the power through a sample that allows us to generalise.

Parametric statistical tests are not appropriate given the small size of the subjects who suffered bites.

The univariate analyses alone do not seem to us to be at all robust for a good generalisation.

Reviewer #3: The study addresses a neglected public health issue using the HDDS data. It is good for the general public also in that it is highlighting treatment gaps such as the absence of antivenom at local health centers and the predominant reliance on traditional healers. There is an opportunity for a public health impact by targeting traditional healers as critical stakeholders in snakebite management.

Reviewer #4: Introduction

Line 87: Delete a space after in 2017

Lines 97-102: It is important here to specify whether these statistics concern the world or a given region.

Line 107: Please specify the scientific name of the viper species in question, in particular Echis carinatus.

Line 114 delete “- ‘ after ’national Household

Line 114-119: Here, you discuss national data for Côte d'Ivoire on snakebite incidence and mortality, based on a source from the 200th century, whereas more recent figures have been produced by studies by Habib et al. (2015). Why did you choose this option?

Line 147 study area

It's important here to better present or explain HDSS. Is HDSS a digital data collection platform or a research station? I read that “Le Système de Surveillance Sanitaire et Démographique de Taabo is a research station of the Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS) located in south-central Côte d'Ivoire, about 150 km northwest of Abidjan.” If this is the case, I think that the title of the manuscript needs to be revised, in particular to read: “based on HDSS”. In any case, it is important to better explain the content of the HDSS.

Results

Line 311-313: Why did none of the victims receive antivenom when this is the main treatment recommended in hospitals? It would be important to mention the reason for this.

Line 314-315. It would be important to identify and mention the scientific names of the snakes responsible for the envenomations.

Discussion

Line 409: Delete “[”.

Line 410-411: Complete this sentence with : “and are therefore not overly involved in the rural activities that are the main source of snakebites.”

Line 455: Please specify the scientific name of the spitting cobra.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Naila Baig-Ansari

Reviewer #4: Yes:  DOSSOU Ayékotchami Jacques Calver, PhD

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012983.r004

Decision Letter 1

Wuelton Monteiro

13 Mar 2025

Dear Mr N'KRUMAH,

We are pleased to inform you that your manuscript 'Survey on the burden, epidemiological and clinical characteristics of snakebite envenoming in the Health Demographic Surveillance System (HDSS) of Taabo (Southern Côte d'Ivoire)' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Wuelton Monteiro, Ph.D.

Section Editor

PLOS Neglected Tropical Diseases

Wuelton Monteiro

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012983.r005

Acceptance letter

Wuelton Monteiro

Dear Mr N'KRUMAH,

We are delighted to inform you that your manuscript, "Survey on the burden, epidemiological and clinical characteristics of snakebite envenoming in the Health Demographic Surveillance System (HDSS) of Taabo (Southern Côte d'Ivoire)," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE Checklist.

    Statement—checklist of items that should be included in reports of observational studies.

    (PDF)

    pntd.0012983.s001.pdf (19.4KB, pdf)
    S1 File. Survey form on snakebite envenoming in the Ahondo health area (Taabo HDSS - Côte d’Ivoire).

    (PDF)

    pntd.0012983.s002.pdf (220.1KB, pdf)
    Attachment

    Submitted filename: RESPONSE-TO-REVIEWERS_PNTD-D-25-00039.pdf

    pntd.0012983.s004.pdf (259KB, pdf)

    Data Availability Statement

    All relevant data are included in the manuscript and its supporting information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES